No Data
Express News | Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)
Express News | Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target
Sunshine Biopharma Analyst Ratings
Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 MRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
Sunshine Biopharma Launches a New Generic Prescription Drug
US Manufacturing Index Rises To 43, Highest Since 2020
MARKET-TEST-DUMMY : Will face pressure, on a longggggg grind
Rhiox OP MARKET-TEST-DUMMY : I don't think this will hold up long, really didn't expect it to go over 2.71 and I thought the dip earlier would be a tad bit lower. Still think it's gonna retrace back soon.
Rhiox OP MARKET-TEST-DUMMY : now look at the gap between bid and ask